Clinical Trials Directory

Trials / Completed

CompletedNCT04977817

Probiotics/TPN in the NICU

A Prospective/Retrospective Chart Review of the Effects of a Probiotic Dietary Supplement on Days of Total Parenteral Nutrition in Two Neonatal Intensive Care Units

Status
Completed
Phase
Study type
Observational
Enrollment
150 (actual)
Sponsor
Pediatrix · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the effect of probiotic administration on TPN dependence in infants \< 32 weeks GA and BW 1500 grams or less in the Banner - University Medical Center Phoenix and Banner Children's at Desert Neonatal Intensive Care Units (NICU). The primary endpoint of capturing the number of days of TPN administration can reflect that an infant is progressing towards readiness for the initiation or advancement of enteral feedings at an earlier interval. The relationship between probiotic administration and the incidence of NEC, culture positive sepsis, and mortality is of interest to us and will be captured. Finally, the assessment of the tolerance of probiotic administration and the potential positive impact on growth and development in these premature infants may validate our current practices.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTSimilac Probiotic Tri-BlendProbiotic dietary supplement, Similac Probiotic Tri-Blend

Timeline

Start date
2021-11-03
Primary completion
2022-08-01
Completion
2022-08-26
First posted
2021-07-27
Last updated
2022-08-29

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT04977817. Inclusion in this directory is not an endorsement.